Apple AirPods Pro 3 vs Otofonix Encore

The Apple AirPods Pro 3 is a budget-priced OTC hearing aid available at $250, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This visible-in-ear device ranks #49 of 65 OTC hearing aids tested, placing it in the top 74% of its category. The standout performance area is music streaming, scoring a strong 4.3/5—a full 2.38 points above the category average. Feedback handling is excellent at 5.0/5, meaning users can expect stable performance without whistling during normal use. However, speech performance presents a more mixed picture: speech in quiet scores 2.3/5, falling 0.53 points below the category average, while speech in noise scores 1.8/5—above the category average but low in absolute terms. Own-voice comfort is a notable weakness at 1.9/5, scoring 0.61 points below the category average, which may affect how natural your own speech sounds while wearing the devices. The product showed meaningful improvement from tuning, with the normalized score rising from 3.2/5 to 3.8/5 after adjustment. The AirPods Pro 3 is best suited for users who prioritize music streaming quality and seamless Apple ecosystem integration over maximum speech clarity. Budget-conscious shoppers should note that several competitors in the same price range—including the Elehear Beyond and the previous-generation Apple AirPods Pro 2—achieved higher overall scores in our testing.

The Otofonix Encore is a budget-priced prescription hearing aid available for $295, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This behind-the-ear device ranks #37 of 39 in the Prescription Hearing Aid category, placing it in the bottom tier of its class. In our standardized testing, the Encore demonstrates one clear strength: excellent feedback handling at 4.7/5, which means users are unlikely to experience whistling or squealing during normal use. However, the device shows significant limitations in other areas. Speech intelligibility scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.40 and 1.11 points below category averages respectively. Music streaming performance scored 0.0/5, indicating this device is not suitable for those who want to stream audio content. The Encore uses disposable batteries and comes in a traditional behind-the-ear style. Notably, our tuned fit testing showed a slight decrease in overall performance compared to the initial fit, with the normalized score dropping from 2.8/5 to 2.4/5. Own-voice comfort also declined substantially when moving to a more occluding coupling. At this price point, consumers may want to consider alternatives. The RxEars Rxi offers substantially better performance at a similar budget price point with a score of 4.07/5. The Otofonix Encore may appeal to buyers seeking a very low-cost entry into prescription hearing aids who prioritize feedback stability, but those needing reliable speech clarity or streaming capabilities should explore other options.